fashion -WSS

fashion

author：knowledge 2025-09-03 14:42:37 - browse：48374

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Leon Gautier, last member of French D

WSS

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

FDA warns medical device makers about rise in fabricated data

Secretariat’s lessons for human medicine

Surprise medical billing ban raises prices elsewhere

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

focus

fashion

leisure time

In Memoriam: Notable people who died in 2023

Congress may force more Covid

Medicare proposal to cover medical devices draws a mixed reaction

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

Medical leaders decry Supreme Court decision on affirmative action

Elon Musk announces 'temporary limits' for reading Twitter posts

Bright Health sells Medicare Advantage business to Molina

Obamacare plans could cover weight loss drugs

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Ukraine seeks to reclaim its role as a hub for clinical trials

hotspot

Surprise medical billing ban raises prices elsewhere

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

As AI regulations shape up, health tech startups beg for clarity

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Researchers tackle phage therapy hurdles for wider adoption

knowledge

hotspot

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power planthttps://s.abcnews.com/images/International/ukraine-nuclear-power-plant-rt-jt-230701_1688223749213_hpMain_16x9_608.jpg2:13TheZaporizhzhiaNuclearPowerPlantisshownoutsideEnerhodarintheZaporizhzhiaregion,Russian-controlle

focus